Drug Approved to Treat Smallpox After a Bioterrorist AttackAschenbrenner, Diane S., MS, RNAJN The American Journal of Nursing: November 2018 - Volume 118 - Issue 11 - p 21 doi: 10.1097/01.NAJ.0000547660.47166.0f Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics A new antiviral drug, tecovirimat (TPOXX), has been approved to treat smallpox. Public health scientists have raised concerns that variola virus, which causes smallpox, could be released in a bioterrorist attack, creating a public health emergency. Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: firstname.lastname@example.org. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.